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Methods: In the Rotterdam Study, 4393 nondemented individuals were followed for incident demen-
tia for 13.7 years by continuous monitoring. Cox proportional hazards models for different time
intervals were used to estimate the risk of incident dementia.
Results: Five-hundred eighty-two participants developed dementia during 13.7 years. Persons with
depressive symptoms had an 8% increased risk of dementia compared with those without depressive
symptoms during the overall follow-up. The risk was highest in the short and intermediate follow-up,
particularly in men. We did not find an association in the follow-up period beyond 10 years.
Conclusion: Our results suggest that late-life depressive symptoms are part of a dementia prodrome
rather than an independent risk factor of dementia.
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Dementia poses a high burden on society and health care
in terms of financial costs and suffering for patients and care-
givers. Current estimates indicate a prevalence of 35.6
million patients worldwide with another 7.7 million incident
cases occurring annually [1]. To develop effective preventive
and therapeutic strategies, it is crucial to unravel the multi-
factorial etiology of dementia.
Depression and depressive symptoms are very common
in the elderly and often co-occur with dementia [2]. Depres-
sion and dementia share many vascular risk factors [3], and
various studies have shown that depression in late life is
associated with a 2- to 5-fold increased risk of dementiathor. Tel.:131-10-7043475; Fax:131-10-7044657.
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16/j.jalz.2013.10.006[4–8]. Most studies investigated this association over a
follow-up period of at most 7 years. In contrast, the Framing-
ham study analyzed a follow-up period of 17 years and re-
ported a 70% greater risk of incident dementia in
depressed individuals; however, the investigators did not
distinguish the risk between short- and long-term follow-
up. Taken together, current data suggest a strong association
between depression and incident dementia, but the question
remains whether depression is a risk factor for dementia or
merely a prodromal symptom of underlying dementia [9].
Given the long preclinical phase of dementia, it is conceiv-
able that subclinical dementia causes depressive symptoms
rather than depression being a true risk factor for dementia.
One way to address this issue is to study the association of
depression and dementia during a long follow-up and then
explore the association over separate incremental periods
of follow-up. The hypothesis to be tested is that there is aeserved.
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short follow-up period that attenuates with longer follow-up.
In addition, some studies have suggested a difference be-
tween men and women in the association of depression with
dementia, but data are still scarce. Therefore, we studied the
relationship of depressive symptoms and dementia over long
and short follow-up periods in a population-based cohort.
We further examined if the relationship between depression
and dementia differs between men and women.2. Methods
2.1. Setting
This study was embedded in the Rotterdam Study, which
is an ongoing population-based prospective study of the
elderly that started in 1990 and studies the incidence and de-
terminants of chronic diseases in late life [10]. The Medical
Ethics Committee of Erasmus Medical Center Rotterdam
approved the study, and a written informed consent was ob-
tained from all participants.
Every 3 to 4 years, all participants undergo an extensive
home interview and a physical examination at the research
center. In addition, all participants are continuously moni-
tored for the occurrence of all major events during follow-
up by linkage of the study database with medical files
from general practitioners. The third examination round of
the Rotterdam study constituted the baseline of this study
because the data on depressive symptoms were complete
and uniformly collected (using the Center for Epidemiology
Depression Scale [CES-D] for the whole cohort).
2.2. Study population
Of the original cohort of 7983 persons in 1990, 4797 sur-
viving persons participated at the third examination that took
place from 1997 to 1999. From these 4797 individuals, 4602
(96%) completed the depression assessment questionnaire.
Of these 4602, 110 participants did not consent to undergo
dementia screening and were excluded. We also excluded
92 participants who were demented at baseline and 7 who
were lost to follow-up. This yielded a total of 4393 individ-
uals (92% of total survivors) available for final analysis who
were followed for a maximum of 13.7 years (mean 8.7, stan-
dard deviation [SD] 3.5 years) for incident dementia.
Follow-up started from the day of depressive symptom
screening to the date of incident dementia, date of death,
or the censor date January 1, 2011, whichever occurred first.
2.3. Assessment of depression
We used the validated Dutch version of the CES-D for
assessment of depressive symptoms at baseline. The CES-
D comprises 20 questions, each with a possible score of
0 to 3, and the score indicates clinically relevant depressive
symptoms. Depressive symptom scores were used as a stan-
dardized continuous variable. z scores were calculated asweighted individual score minus mean score divided by
the standard deviation. CES-D scores were weighted by
missing values only if missing values did not exceed 25%.
However, for descriptive purposes, a score of 16 or higher
is considered suggestive of depressive symptoms [11].2.4. Assessment of incident dementia
Participants were screened for dementia at baseline and
follow-up examinations using a three-step protocol [12].
Screening was done using the Mini-Mental State Examina-
tion (MMSE) [13] and the Geriatric Mental Schedule
(GMS) organic level [14]. Screen-positives (MMSE , 26
or GMS organic level . 0) subsequently underwent an ex-
amination and informant interview with the Cambridge Ex-
amination for Mental Disorders in the Elderly (CAMDEX)
[15]. Participants who were suspected of having dementia
underwent, if necessary, further neuropsychological testing.
In addition, the total cohort was continuously monitored for
dementia through computerized linkage between the study
database and digitized medical records from general practi-
tioners and the Regional Institute for Outpatient Mental
Health Care. In the end, a consensus panel, led by a neurol-
ogist, decided on the final diagnosis in accordance with stan-
dard criteria using the Diagnostic and Statistical Manual of
Mental Disorders, third edition, revised (DSM-III-R) criteria
for dementia and the National Institute of Neurological and
Communicative Disorders and Stroke (NINCDS)-
Alzheimer’s Disease and Related Disorders Association
(ADRDA) for Alzheimer’s disease [16]. If required for dif-
ferential diagnosis, neuroimaging was used. Follow-up for
incident dementia was virtually complete (98.63%) until
January 1, 2011.2.5. Covariates
In addition to age and gender, education level, smoking,
cognition level at baseline, hypertension, diabetes mellitus,
prevalent stroke, and use of antidepressant medication
were considered possible confounders. Smoking, hyperten-
sion, diabetes, and stroke are well-documented risk factors
for all types of dementia. A low education level has been
found to be associated with increased risk of dementia,
especially in females [17]. In subsequent models, we
also adjusted for marital status, APOE- 34 (APOE 32/ 34,
APOE 3 / 34 or APOE 34/ 34) carrier status, cognitive com-
plains at baseline, and psychotropic medication use.
Education level was assessed during the interview, and
people were classified into two categories: low level of edu-
cation (primary only or primary and unfinished secondary)
and intermediate to high (primary and secondary, vocational,
or university) level of education. Cognition was assessed by
the MMSE at baseline [13]. Inquiring about smoking habits,
participants were categorized into current, former, and never
smokers. Blood pressurewas measured twice at the right arm
in sitting position at the research center; the average of two
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as systolic blood pressure of 140 mmHg or greater, diastolic
blood pressure of 90 mmHg or greater, or use of antihyper-
tensive medication assessed by interview and pharmacy re-
cords [18]. Diabetes mellitus type II was diagnosed as
fasting blood glucose of 126.13 mg/dL (multiply by factor
0.0555 to covert to mmol/L) or greater or use of antidiabetic
medication evaluated by interview and pharmacy records
[19]. Previous stroke was determined by reported events
on interview and confirmed by medical records. In addition,
participants are continuously monitored for all major events
through automated linkage of the study database with gen-
eral practitioner (GP) files [20]. Information on use of anti-
depressants (ATC code n06) was obtained by interview and
medical and pharmacy records.Table 1
Baseline characteristics of the study population, RS-I-3 (N 5 4393)
Characteristics Descriptives
Females, n (%) 2599 (59.2)
Age, mean (SD), years 72.7 (7.3)
BMI, mean (SD) 26.86 (3.7)
Education
Low level of education 1350 (31.2)
Intermediate to high 2980 (68.8)
Smoking status, n (%)
Never 1520 (34.6)
Former 2157 (49.1)
Current 716 (16.3)
Diabetes, n (%) 534 (12.2)
Stroke, n (%) 338 (7.7)
Myocardial infarction, n (%) 427 (9.7)
Hypertension, n (%) 2990 (68.1)
Total cholesterol (mmol/L), mean (SD) 5.82 (0.9)
HDL (mmol/L), mean (SD) 1.39 (0.4)
Antipsychotic use, n (%) 642 (14.6)
Antidepressant use, n (%) 135 (3.1)
Clinically relevant depressive symptoms,
n (%)
323 (7.4)
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein;
RS-I-3, Rotterdam study cohort I examination round 3; SD, standard de-
viation.2.6. Statistical analysis
We used the Cox proportional hazards model to assess the
relationship between clinically relevant depressive symp-
toms and incident dementia (all cause). We investigated
not only the total follow-up period as a whole, but also sepa-
rate 5-year time periods (0–5 years, 5–10 years, and
.10 years of follow-up). This analysis was performed to
study the timing of incident dementia in relation to the
appearance of depressive symptoms. However, several
studies have used a follow-up time range of 1 to 5 years to
study the short-term effect of depression on dementia inci-
dence [5,6,21–24]; there is no recommended cutoff of
follow-up time to study depression as a dementia prodrome.
In an alternative analysis, time periods were defined by
ensuring an equal number of 100 cases in each period (five
periods of 100 incident cases, the last period only counted
82 cases). This approach allows a more detailed assessment
of risk ratio change over time and increases the power to
detect changes. Hazard ratios (HRs) of dementia for each
time period of 100 cases were calculated separately and
cumulatively. The cumulative time approach in the main
analysis and in the 100-case analysis was a method per-
formed to ensure comparability with other studies because
most studies have examined the association of depressive
symptoms and dementia using a Cox model and using vari-
able follow-up periods. Therefore, we first used a cumulative
follow-up approach in which we examined the association
between depression and dementia by increasing the years
of follow-up by not changing the baseline (i.e., 0–5 years,
0–10 years, and 0–13.7 years). Likewise, for the 100-case
analysis, we examined the association of depression and de-
mentia by increasing 100 incident cases in every subsequent
step without changing our baseline (i.e., baseline to first 100
incident cases, baseline to first 200 cases, baseline to first
300 cases, etc.).
As secondary analyses, we explored effect modification
by gender and age (median used as cutoff) using stratifica-
tion and interaction terms. In addition, we analyzed our
data using only Alzheimer’s disease as an outcome. Finally,we repeated our analysis using depressive symptoms dichot-
omized at a cutoff of 16 points on the CES-D.
We ran an additional analysis to test the sensitivity of our
findings. The analysis was repeated excluding persons with
clinically relevant depressive symptoms occurring before
baseline. Depressive symptoms were also assessed, 4 years
before baseline either with the CES-D (cutoff  16) in
48% of participants or the Hospital Anxiety and Depression
Scale (HADS; cutoff 9) in 52% of participants, as part of a
pilot [25]. In this sensitivity analysis, the effect of more
chronic depressive symptoms, which are less likely to be
an indicator of a dementia prodrome, is reduced. If there
were an effect of depression as part of a dementia prodrome
only, then our HR for the short follow-up would be expected
to increase slightly if chronic cases are excluded.
Because depressive symptoms in the Rotterdam Study
were remeasured at a follow-up round in 2002 to 2004, we
also repeated our analysis using depressive symptoms as-
sessed at this follow-up round as our baseline.
Results are presented as HR with 95% confidence inter-
vals (CIs). All analyses were adjusted for age and gender
in the first model and additionally for education, smoking,
hypertension, diabetes, prevalent stroke, MMSE score, and
antidepressant use in the second model. Data were analyzed
using the Stata Software Version 12 (StataCorp, College
Station, TX).
3. Results
Baseline characteristics of the study population are sum-
marized in Table 1. The study included 4393 individuals,
59% of which were females (n 5 2599). Mean age at
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105.8 years), and participants were followed for a maximum
of 13.7 years (mean 8.7, SD 3.5 years). Applying the
accepted cutoff of 16 or greater for CES-D, 7% (n 5 323)
of the study population had clinically relevant depressive
symptoms at baseline; however, we used continuous depres-
sion scores for all analyses.
Of the 4393 individuals, 13% (n 5 582) developed de-
mentia (all cause); 84% of those were Alzheimer’s disease
cases (n 5 489). The mean age of dementia diagnosis was
83 years (SD 6.3 years; range 65.5–102 years).
When investigating each time period with 100 subsequent
cases separately, the risk of dementia decreased gradually
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dementia-effect estimates per 100 consecutive incident dementia cases. (A) De
(B) Depressive symptoms and risk of incident dementia with cumulatively increas
groups of 100 patients according to incidence of dementia. Hazard ratios for these
additional cases is used to plot the graphs. The circles represent the hazard ratios aHR 0.89, 95% CI 0.69–1.15 in the last period. A similar
pattern was observed when we calculated hazards for cumu-
lative time periods of 100 cases; HR 1.24, 95% CI 1.06–1.44
in the first period to HR 1.11, 95% CI 1.03–1.20 in the last
period (Fig. 1).
In the overall follow-up of 13.7 years, depressive symp-
tomswere associatedwith amoderately increased risk of inci-
dent dementia (Table 2). During a shorter follow-up time (i.e.,
5 years from baseline), depressive symptomswere associated
with a high risk of incident dementia (fully adjusted HR 1.13,
95% CI 1.01–1.27). The same was true for the period of 5 to
10 years follow-up (HR 1.14, 95%CI 1.01–1.29). In contrast,
we did not find any relationship in the third follow-up period
in the fully adjusted model (HR 0.83, 95% CI 0.66–1.04)n Years
8 10 12
n Years
8 10 12
 % Confidence Intervals
ementia per follow-up interval
mentia with cummulatively increasing follow-up
ressed individuals (N 5 4393). Depressive symptoms and risk of incident
pressive symptoms and risk of incident dementia per follow-up interval.
ing follow-up. Total number of dementia cases (n 5 582) were split in sub-
100 cases were calculated. Mean follow-up time for each subgroup of 100
nd the lines represent the 95% confidence intervals. CI, confidence interval.
Table 2
Clinically relevant depressive symptoms and risk of incident dementia—overall and gender split analysis (N 5 4393)
Depressive symptoms
Follow-up time in years
Overall follow-up 0–5 years 5–10 years 10–13.7 years
Cases/n 582/4393 222/4393 238/3529 122/2554
Depressive score, (per SD)* 1.11 (1.03–1.20) 1.19 (1.07–1.33) 1.15 (1.03–1.29) 0.84 (0.68–1.05)
Depressive score, (per SD)y 1.08 (1.00–1.17) 1.13 (1.01–1.27) 1.14 (1.01–1.29) 0.83 (0.66–1.04)
Males (n 5 1794)
Cases/n 176/1794 62/1794 71/1416 43/985
Depressive score, (per SD)* 1.20 (1.02–1.41) 1.51 (1.23–1.86) 1.20 (0.91–1.58) 0.40 (0.17–0.93)
Depressive score, (per SD)y 1.04 (0.88–1.24) 1.31 (1.04–1.66) 1.06 (0.79–1.41) 0.38 (0.16–0.93)
Females (n 5 2599)
Cases/n 406/2599 160/2599 167/2113 79/1569
Depressive score, (per SD)* 1.09 (1.01–1.19) 1.12 (0.99–1.27) 1.14 (1.01–1.30) 0.94 (0.75–1.18)
Depressive score, (per SD)y 1.09 (1.00–1.18) 1.10 (0.96–1.26) 1.15 (1.01–1.31) 0.92 (0.73–1.15)
Abbreviation: SD, standard deviation.
NOTE. Cases refer to incident dementia cases. Data are presented as hazard ratio (95% confidence interval). Depression is taken as a continuous standardized
variable using the Center for Epidemiologic Studies Depression Scale scores.
*Age and gender adjusted.
yAdditionally adjusted for smoking, education, hypertension, diabetes, prevalent stroke, Mini-Mental State Examination score, and antidepressant use.
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APOE- 34 carrier status (APOE 32/ 34, APOE 3 / 34 or APOE
34/ 34), cognitive complaints at baseline, and use of psychotro-
pic drug use, our results remained unchanged.
In a secondary gender split analysis, we found a more
pronounced effect in men than in women, although the over-
all pattern in both sexes was similar to the main analysis
(Table 2). However, in depressed men, the risk of dementia
in the 10- to 13.7-year interval was reduced by 60%
(HR 0.38, 95% CI 0.16–0.93). The interaction for gender
was statistically significant (P , .001). Interaction for age
was not significant; hence, it is not shown.
Repeating all analyses using Alzheimer’s disease as the
outcome yielded similar results and patterns
(Supplementary Table 1). Results using depressive symp-
toms as a dichotomized variable also showed a similar
pattern as our main analysis (Supplementary Table 2).
In the sensitivity analysis, after excluding individuals
who had been screened positive for clinically relevant
depressive symptoms 4 years before baseline, the presence
of depressive symptoms showed a 16 % higher risk of inci-
dent dementia in the 0- to 5-year follow-up (HR 1.16, 95%
CI 1.02–1.32). Using depressive symptoms assessed at the
2002 to 2004 examination round, we found a similar pattern
of results as the main analysis (data not shown).4. Discussion
We found that persons with depressive symptoms had a
higher risk of incident dementia, including Alzheimer’s dis-
ease. These associations were strongest for short follow-up
time and they attenuated with incrementally longer follow-
up periods. Furthermore, the association was more pro-
nounced in men than in women.
Prevalence of depressive symptoms is relatively low in
this cohort. However, it falls within the variable range of2.8% to 35% reported in a review of depressive symptoms
in the elderly [26]. In addition, the Survey of Health, Aging
and Retirement in Europe (SHARE) study has reported the
Netherlands to be one of the lower depression prevalence
countries in Europe [27].
Strengths of the study include the large population-based
cohort followed for over 13 years. However, certain method-
ological considerations need to be mentioned. First, we
included clinically relevant depressive symptoms (assessed
by CES-D) as the determinant rather than diagnosed depres-
sion. Therefore, we cannot be certain about the generaliz-
ability of our results to clinical depressive syndromes as
well. Second, some residual confounding due to unknown
or unmeasured confounders such as physical activity and
diet cannot be completely ruled out.
Third, there is a possibility that some selection through
depressive symptomsand/or cognitive function in the previous
examination round may have influenced the results. Fourth,
depressive symptoms were related to death of participants in
the first 10 years of follow-up; therefore, there is a possibility
of some selection by death in the 10- to 13.7-year interval.
There are a few possible explanations for our observa-
tion that the association of depression with incident demen-
tia was strongest with short follow-up and attenuated with
longer follow-up. First, late-onset depressive symptoms
preceding dementia could be merely a reactive phenome-
non. It is possible that depression is a psychological
response to the ongoing cognitive decline [28]. Second,
late-onset depressive symptoms may represent a prodrome
of dementia. The prodrome can be defined as a predementia
syndrome in which the underlying subclinical dementing
process manifests itself by depression or altered behavior,
thus marking the onset of clinical dementia in the near
future. Whereas a depression in adult life or a lifetime his-
tory of depression would be considered a risk factor for de-
mentia, a very recent history of late-onset depressive
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derlying neurodegenerative condition. This implies that
depression and dementia are the result of a common under-
lying process or processes, but that symptoms of depression
manifest earlier than dementia. It has been shown that
patients experiencing cognitive decline together with late-
onset depression develop dementia within a few years after
the onset of depression [28]. This prodromal hypothesis is
in line with recent findings from large cohort studies sug-
gesting that late-onset depression is a prodrome of demen-
tia onset [21,29]. Studies have reported a positive
association between depression and dementia over a
shorter follow-up period of at most 5 years [4–7]. In a
subset of the Rotterdam Study, we previously reported a
null association between depressive symptoms and de-
mentia; however, differences in sample size, follow-up,
age, and cognition at baseline could explain the difference
in results [30].
Third, depression may only increase the risk of dementia
over a short-term period. Some individuals with depressive
symptoms may be more vulnerable for incident dementia
because of certain genetic or environmental risk factors,
although a shared etiology would typically convey a con-
stant risk over time [3,31]. Several potential biological
mechanisms could be a common intermediate between
depression and dementia, such as hippocampal atrophy
[2]. It has also been shown that depressed individuals have
low levels of adrenaline [32] and serotonin [33], and deficits
of these monoamines are also associated with increased
severity of dementia.
The underlying neurodegenerative process might get
accelerated because of depression by the activation of hippo-
campal pituitary axis leading to increased cortisol levels,
hence precipitating dementia [28]. We also found that the as-
sociation of depressive symptoms and dementia in the short-
term period was stronger in men than in women. This finding
concurs with two prospective cohort studies that reported a
stronger association of depressive symptoms and risk of inci-
dent dementia in men compared with women [34,35]. There
is limited literature available in this context, and further
epidemiological and etiological studies are highly
recommended to better understand the gender differences
in the association between depression and dementia.
We observed a protective association between depression
and dementia in the 10- to 13.7-year interval in men. How-
ever, because this period has a fewer number of cases
(n 5 43), the estimates may not be very precise. It is also
possible that reduced effect estimates are a result of other
competing risks in this period and deaths occurring due to
other causes such as cardiovascular causes or cancers. In
addition, we speculate that perhaps depressed persons who
survive 10 years or more become resilient against subse-
quent dementia.
In conclusion, late-onset depressive symptoms represent
a part of the prodromal stage of dementia rather than being
a risk factor for dementia. Depressive symptoms posed amuch higher risk of incident dementia in men compared
with women in a short follow-up.
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1. Systematic review: We reviewed the literature using
PubMed for articles describing depression and risk of
dementia. We cite several studies showing a link be-
tween late-life depression and risk of incident de-
mentia. In our study, we investigated the association
of late-onset depression and dementia in short- and
long-term follow-up to disentangle whether late-
onset depression is a risk factor or a prodrome of
dementia.
2. Interpretation: We found that depressive symptoms
predict incident dementia in the short term, but not
in the long term, especially in men. This suggests
that late-onset depression is a prodrome of demen-
tia rather than a risk factor.
3. Future directions: Future studies should unravel the
biological mechanisms underlying this association.
If depression is indeed a prodrome of dementia,
then this may aid to identify, at an early stage, per-
sons at high risk of clinical dementia. Another focus
should be on unraveling the differences between
males and females regarding the association of
depression and dementia.
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Supplementary Table 1
Clinically relevant depressive symptoms and risk of Alzheimer’s disease (N 5 4393)
Depressive symptoms
Follow-up time in years
Overall follow–up 0–5 years 5–10 years 10–13.7 years
Cases/n 489/4393 194/4393 199/3529 96/2554
Depressive score, (per SD)* 1.08 (0.99–1.17) 1.16 (1.03–1.31) 1.11 (0.98–1.27) 0.79 (0.61–1.03)
Depressive score, (per SD)y 1.05 (0.96–1.15) 1.11 (0.98–1.26) 1.09 (0.95–1.25) 0.79 (0.60–1.04)
Males (n 5 1794)
Cases/n 131/1794 43/1794 55/1416 33/985
Depressive score, (per SD)* 1.16 (0.95–1.41) 1.38 (1.04–1.82) 1.30 (0.98–1.73) 0.43 (0.17–1.06)
Depressive score, (per SD)y 1.02 (0.83–1.25) 1.16 (0.83–1.60) 1.13 (0.83–1.53) 0.48 (0.19–1.22)
Females (n 5 2599)
Cases/n 358/2599 151/2599 144/2113 63/1569
Depressive score, (per SD)* 1.07 (0.97–1.17) 1.13 (0.99–1.28) 1.08 (0.93–1.24) 1.08 (0.93–1.24)
Depressive score, (per SD)y 1.06 (0.96–1.16) 1.11 (0.97–1.27) 1.07 (0.92–1.25) 1.07 (0.92–1.25)
Abbreviation: SD, standard deviation.
NOTE. Cases refer to incident dementia cases. Data are presented as hazard ratio (95% confidence interval). Depression is taken as a continuous standardized
variable using the Center for Epidemiologic Studies Depression Scale scores.
*Age and gender adjusted.
yAdditionally adjusted for smoking, education, hypertension, diabetes, prevalent stroke, Mini-Mental State Examination score, and antidepressant use.
Supplementary Table 2
Clinically relevant depressive symptoms and risk of incident dementia (N 5 4393)
Depressive symptoms
Follow-up time in years
Overall follow-up 0–5 years 5–10 years 10–13.7 years
Cases/n 582/4393 222/4393 238/3529 122/2554
Depressive symptoms* 1.46 (1.13–1.89) 1.43 (0.96–2.15) 1.94 (1.33–2.82) 0.74 (0.34–1.59)
Depressive symptomsy 1.38 (1.06–1.80) 1.26 (0.83–1.91) 1.94 (1.31–2.87) 0.74 (0.34–1.60)
NOTE. Cases refer to incident dementia cases. Data are presented as hazard ratio (95% confidence interval). Depression is used as dichotomized variable
(cutoff Center for Epidemiologic Studies Depression Scale score  16 taken as positive for depressive symptoms).
*Age and gender adjusted.
yAdditionally adjusted for smoking, education, hypertension, diabetes, prevalent stroke, Mini-Mental State Examination score, and antidepressant use.
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